Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers

Completed · Phase 1 · Has a placebo group

Conditions studied: Safety and Tolerability

In brief

This study will test single doses of the study drug in increasing amounts to see if it is safe.

Key facts

Study ID

NCT01952548

Run by

Kowa Research Institute, Inc.

Starts

2013-05-01

Last updated by the study team

2013-12-31

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject provides written informed consent before any study-specific evaluation is performed.
• Subject is a healthy adult male or a female of non-childbearing potential between the ages of 18 and 45 years, inclusive.
• Subject has a body mass index of 18.5 to 32 kg/m2, inclusive.

You may not qualify if…

• Subject is a woman who is of childbearing potential or is breastfeeding.
• Subject has the presence of an active or recurring clinically significant cardiovascular, pulmonary, renal, endocrine, hepatic, neurologic, psychiatric, immunologic, hematologic, gastrointestinal, or metabolic disease requiring medical treatment.

Where it is running

• Study site — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.